The Breo Ellipta price is high because it’s a combination inhaler containing both a corticosteroid and a long-acting bronchodilator. It’s designed for once-daily management of COPD and asthma, requiring advanced manufacturing and inhalation technology. Prescription Bliss connects patients directly to manufacturer-backed programs that significantly reduce those costs.

The Breo Ellipta 100/25 price — one of the most commonly prescribed strengths — typically runs between $500 and $600 per inhaler at retail. Through Prescription Bliss, patients can access the same Breo Ellipta 100/25 for a flat $49 per month, shipped directly from the manufacturer once approved.

Yes. Prescription Bliss helps uninsured or self-pay patients qualify for verified manufacturer programs that make Breo Ellipta affordable. Once approved, you’ll pay $49 per month for one medication or $90 per month for two or more, with all paperwork and renewals handled for you.

Patients who are uninsured, under-insured, or paying high out-of-pocket costs may qualify for Breo Ellipta assistance through Prescription Bliss. You’ll need a valid Breo Ellipta prescription and to meet the manufacturer’s income requirements. Once approved, your medication is delivered directly to you from the manufacturer.

Most patients begin receiving Breo Ellipta within 2–3 weeks after approval. Prescription Bliss coordinates directly with the manufacturer to make sure your savings stay active and your medication deliveries stay consistent.